Categories: News

Emerald Health Therapeutics to Host 2021 Second Quarter Financial Results Conference Call on Tuesday, August 31, 2021 at 10:30 AM ET

Vancouver, British Columbia–(Newsfile Corp. – August 25, 2021) – Emerald Health Therapeutics, Inc. (CSE: EMH) (OTCQX: EMHTF) (“Emerald”) today announced that it will report its financial results for the second quarter ended June 30, 2021, after the market close on Monday, August 30, 2021. The company will host a conference call on Tuesday, August 31, 2021, at 10:30 a.m. ET.

To access the audio broadcast, please dial (866) 652-5200, or via the internet at: 
https://services.choruscall.com/mediaframe/webcast.html?webcastid=BaOdjlDg

An archived version of the presentation will be available for 90 days on the “Investors” section of Emerald’s website:
https://emeraldhealth.ca/investors/events-and-presentations/

About Emerald Health Therapeutics

Emerald is committed to creating new consumer experiences with distinct recreational, medical and wellness-oriented cannabis products, with an emphasis on science-based innovation and product excellence.

Please visit www.emeraldhealth.ca for more information or contact:

Jenn Hepburn, Chief Financial Officer
(800) 757 3536 Ext. #5

Emerald Investor Relations
(800) 757 3536 Ext. #5
invest@emeraldhealth.ca

Neither the Canadian Securities Exchange nor the Market Regulator (as that term is defined in the policies of the Canadian Securities Exchange) accepts responsibility for the adequacy or accuracy of this release.

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/94337

Staff

Recent Posts

ZetrOZ System’s sam(R) Ultrasound Treatment Helps Top Triathlete Return to the Boston Marathon

Former triathlon champ Claudia McCoy used the breakthrough wearable ultrasound unit to boost her recovery…

2 hours ago

Coro Medical Prepares to Roll Out Project AED365 Nationwide Donation Initiative

Project AED365 Aims to Empower Communities, Youth Organizations, First Responders, and more by Providing Lifesaving Automated…

5 hours ago

NLS Pharmaceutics Ltd. and Kadimastem Ltd. Announce Filing of F-4 Registration Statement with the SEC Ahead of Proposed Merger

The proposed transaction will create a Nasdaq-traded, biotechnology company with product candidates in advanced stages…

5 hours ago

Blazesoft Spreads Holiday Cheer with $250,000 Donation to Mackenzie Health Foundation

This heartfelt donation demonstrates Blazesoft's commitment to corporate social responsibility with a generous gift to…

5 hours ago

Inogen Receives FDA 510(k) Clearance for SIMEOX 200 Airway Clearance Device

GOLETA, Calif.--(BUSINESS WIRE)--$INGN #AirwayClearance--Inogen, Inc. (Nasdaq: INGN), a medical technology company offering innovative respiratory products…

8 hours ago

Bemax Inc. Announces Second Quarter Financial Results

- Revenue grew to $1,078,090, an increase of over $1million year-over-yearDallas, Georgia--(Newsfile Corp. - December…

8 hours ago